Follow The Filings

OSTX OS Therapies

OS Therapies earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.20 —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,3.02,8.01,9.01
8-K 1.01,5.02,8.01,9.01
424B7 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
8-K 5.02,5.07,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,9.01
10-Q QUARTERLY REPORT
8-K 1.01,2.03,3.02,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,2.03,3.02,9.01
8-K 1.02
DEF 14A PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K/A 9.01
8-K 1.01,2.03,3.02,5.02,8.01,9.01
10-Q QUARTERLY REPORT
8-K 7.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,8.01,9.01
10-K ANNUAL REPORT
424B7 PROSPECTUS SUPPLEMENT
8-K 8.01,9.01
8-K 1.01,2.03,3.02,9.01
8-K 8.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4/A Period Oct 21, 2025
4 Period Jan 22, 2026 (4 forms)

9 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.